Burges A

No ORCID on file · 12 papers in corpus · active 2009-2026

Study types

  • article 4
  • other 3
  • case-report 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 9
  • chronic_pelvic_pain 2
  • dysmenorrhea 1
  • adenomyosis 1
  • dyspareunia 1
other 2026
Ablation compared with excision in the surgical management of peritoneal endometriosis: a retrospective study of pain, re-operation, and pregnancy outcomes
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08331-4

OBJECTIVE: The study aimed to evaluate the long-term outcomes of surgical management in patients with peritoneal endometriosis, focusing on postoperative pain trajectories, re-operation rates, fertility outcomes, and the potential influence…

case-report 2023
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman
Anticancer research ·doi:10.21873/anticanres.16340

BACKGROUND/AIM: Endometriosis is a common disorder in reproductive-age women leading to a broad range of symptoms and is associated with a higher risk for endometrioid ovarian carcinoma. CASE REPORT: We report the case of a 55 year-old wom…

2022
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
Scientific reports ·doi:10.1038/s41598-022-05785-9

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, t…

review 2022
[Endometriosis - a seriously understimated disease]
MMW Fortschritte der Medizin ·doi:10.1007/s15006-022-2175-2
article 2022
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06730-x

PURPOSE: Endometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with endometri…

preprint 2022
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic. Experience from an academic high level endometriosis centre in Germany.
·doi:10.21203/rs.3.rs-1784980/v1

Abstract PurposeEndometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with e…

2020
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer.
Histochemistry and cell biology ·doi:10.1007/s00418-020-01873-x

Several risk factors like obesity and hyperlipidemia were described for endometrial cancer. Here, the nuclear NAD-dependent histone-deacetylase Sirtuin1 (SIRT1) seems to be important. SIRT1 is also involved in cell regulatory mechanisms and…

article 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only
Oncology letters ·doi:10.3892/ol.2017.6592

The present study aimed to identify differences in protein expression in cases of endometrioid endometrial cancer (EEC) with and without coexisting adenomyosis uteri (AM), and to evaluate the histopathological and prognostic distinctions. T…

article 2012
[Unexplained pelvic pain: is it endometriosis?].
MMW Fortschritte der Medizin ·doi:10.1007/s15006-012-1007-1
article 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
Clinical chemistry and laboratory medicine ·doi:10.1515/cclm.2011.709

BACKGROUND: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy. METHODS: We retro…

other 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-08-0653

Comparative proteomics identified the vitamin E-binding plasma protein afamin as a potential novel tumor marker for ovarian cancer. In addition, we observed in a previous small study decreased plasma concentrations of apolipoprotein A-IV (a…

other 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
Clinical chemistry and laboratory medicine ·doi:10.1515/CCLM.2009.134

BACKGROUND: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT). METHODS: All women diagnosed and treated for BOT at our institution between 1981 a…